Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 1.97% is 69% below its 5-year average of 6.32%, near the low end of its 5-year range (0.00%–29.11%).
As of the fiscal period ended Tuesday, March 31, 2026. 75.58% below its 12-month average of 8.05%.
Reported quarterly debt to assets ratio; no daily interpolation. Q4 FY2025 (2026-03-31): 1.97%.
DEBT TO ASSETS RATIO
1.97%
DEBT TO ASSETS RATIO AVG TTM
8.05%
DEBT TO ASSETS RATIO AVG 3Y
8.64%
DEBT TO ASSETS RATIO AVG 5Y
6.32%
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-75.58%
CURRENT VS 3Y AVG
-77.23%
CURRENT VS 5Y AVG
-68.88%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+2085.56%
vs the sector median at left
Paranovus Entertainment Technology Ltd.
Market Cap
$3.23M
Debt to Assets Ratio
1.97%
TTM Avg
8.05%
3Y Avg
8.64%
5Y Avg
6.32%
Market Cap
$3.21M
Debt to Assets Ratio
0.06%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.30M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.14M
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.07M
Debt to Assets Ratio
0.77%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.94M
Debt to Assets Ratio
0.06%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Paranovus Entertainment Technology Ltd. (PAVS) | $3.23M | 1.97% | 8.05% | 8.64% | 6.32% |
| MBody AI Ltd. (MBAI)vs › | $3.25M | 0.00% | N/A | N/A | N/A |
| Aethlon Medical, Inc. (AEMD)vs › | $3.21M | 0.06% | N/A | N/A | N/A |
| Nexalin Technology, Inc. (NXL)vs › | $3.30M | 0.00% | N/A | N/A | N/A |
| BioRestorative Therapies, Inc. (BRTX)vs › | $3.14M | 0.01% | N/A | N/A | N/A |
| Adagio Medical Holdings, Inc. (ADGM)vs › | $3.07M | 0.77% | N/A | N/A | N/A |
| Mustang Bio, Inc. (MBIO)vs › | $3.49M | 0.00% | N/A | N/A | N/A |
| Eocene Ltd. (EOCN)vs › | $3.50M | N/A | N/A | N/A | N/A |
| Revelation Biosciences, Inc. (REVB)vs › | $2.94M | 0.06% | N/A | N/A | N/A |
| Cadrenal Therapeutics, Inc. Common Stock (CVKD)vs › | $3.53M | 0.00% | N/A | N/A | N/A |
Debt/Assets
2.0%
Debt/Equity
0.02
Current Ratio
8.18
Interest Coverage
-12.9x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-03-31 | 1.97% |
| 2025-09-30 | 15.14% |
| 2025-03-31 | 7.06% |
| 2024-09-30 | 7.19% |
| 2024-03-31 | 29.11% |
| 2023-09-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-09-30 | 2.83% |
| 2022-03-31 | 2.33% |
| 2021-09-30 | 1.92% |
| 2021-03-31 | 1.98% |
| 2020-09-30 | 2.52% |
| 2020-03-31 | 2.39% |
| 2019-09-30 | 2.85% |
| 2019-03-31 | 1.58% |
| 2018-03-31 | 2.80% |
